Pre-Treatment Prediction of Chemoresistance in Second-Line Chemotherapy of Ovarian Carcinoma: Value of Serological Tumor Marker Determination (Tetranectin, YKL-40, CASA, CA 125)

International Journal of Biological Markers - Italy
doi 10.1177/172460080602100302
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

CA-125 Change After Chemotherapy in Prediction of Treatment Outcome Among Advanced Mucinous and Clear Cell Epithelial Ovarian Cancers

Cancer
Cancer ResearchOncology
2009English

Monitoring Ovarian Carcinoma With CA 125, CA 19–9, CA 15–3 and CEA in Serum, Ascites and Tumor Tissue

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
1986English

Second-Line Treatment of Ovarian Cancer

Oncologist
Cancer ResearchMedicineOncology
2000English

EP25.09: Comparison of Diagnostic Value of Using GIRADS System and Ovarian Malignancy Marker Ca-125 in the Preoperational Adnexal Tumours Assessment

Ultrasound in Obstetrics and Gynecology
Nuclear MedicineRadiologyUltrasound TechnologyGynecologyReproductive MedicineRadiologicalImagingObstetricsMedicine
2017English

KIM-1 as a Potential Serological/Urinological Tumor-Associated Marker of Renal Cell Carcinoma and Chemotherapy Nephrotoxicity

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2019English

The Role of CA‐125 in the Management of Ovarian Cancer

Oncologist
Cancer ResearchMedicineOncology
1997English

Second-Line Treatment Options in Hepatocellular Carcinoma

Drugs in Context
Molecular MedicinePharmacology
2019English

YKL-40/CHI3L1 Drives Inflammation on the Road of Tumor Progression

Journal of Leukocyte Biology
AllergyImmunologyCell Biology
2015English

CA 19-9 and CA 125 Determination by Immunoluminometric Assay

Clinical Chemistry and Laboratory Medicine
BiochemistryMedicineClinical Biochemistry
1990English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy